Table 1 General information of the 14 patients with spinal giant cell tumour of the tendon sheath (GCTTS)
From: Giant cell tumour of the tendon sheath of the spine: clinical features and imaging findings
Cases | Age (year) | Gender | Clinical manifestations | Benign/malignant | Initial treatment | Follow-up time (months) | Prognosis |
|---|---|---|---|---|---|---|---|
1 | 32 | Female | Back pain with left upper numbness for 2 years | Benign | Gross total resection | 157 | Recurrence-free survival |
2 | 45 | Male | Back pain | Benign | Gross total resection | 117 | Recurrence after 45 months |
3 | 28 | Male | Neck pain more than 1 year, right upper limb radiating pain and right-hand numbness and weakness for 6 months | Benign | Cytoreductive surgery and postoperative radiotherapy | 76 | Progression-free survival |
4 | 32 | Female | Neck pain for 2 years | Benign | Cytoreductive surgery and postoperative radiotherapy | 74 | Progression-free survival |
5 | 47 | Female | Neck and shoulder pain for 1 year, right upper limb numbness and weakness for 40 days | Malignant | Gross total resection and postoperative radiotherapy | 53 | Recurrence-free survival |
6 | 32 | Male | Thoracic, back and shoulder pain for 2 years | Benign | Gross total resection | Loss to follow-up | – |
7 | 13 | Female | Left upper limb numbness for 1.5 months | Benign | No treatment | Loss to follow-up | – |
8 | 49 | Male | Numbness or weakness of limbs for 6 years | Benign | Cytoreductive surgery and postoperative radiotherapy | 36 | Progression-free survival |
9 | 44 | Male | Thoracic and back pain for 6 months | Benign | Radiotherapy alone | 36 | Progression-free survival |
10 | 38 | Female | Asymptomatic | Benign | Gross total resection and postoperative radiotherapy | 28 | Recurrence-free survival |
11 | 36 | Female | Back pain with numbness in both hands for 1 year | Benign | Gross total resection | 28 | Recurrence-free survival |
12 | 17 | Female | Neck pain for 3 years, upper limbs numbness for 9 months, right lower limb weakness for 2 weeks | Benign | Gross total resection | 8 | Recurrence-free survival |
13 | 31 | Female | Asymptomatic | Benign | No treatment | Loss to follow-up | – |
14 | 39 | Male | Asymptomatic | Benign | No treatment | 30 | Progression-free survival |